Yin Chen

172 Jiangsu Road
Nanjing, 210009, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 19 publications

AI-enabled viral genomics: from virus discovery to host prediction and emerging variant forecasting.

AI-enabled viral genomics: from virus discovery to host prediction and emerging variant forecasting.

Journal: Virology

Published: June 16, 2026

Isolation of neutralizing antibodies against SARS-CoV-2 through an epitope-guided negative screening by phage display.

Isolation of neutralizing antibodies against SARS-CoV-2 through an epitope-guided negative screening by phage display.

Journal: Journal of biomedical research

Published: November 27, 2025

A microchip electrophoresis method for rapid nucleic acid extraction and bacteria detection.

A microchip electrophoresis method for rapid nucleic acid extraction and bacteria detection.

Journal: Talanta

Published: January 23, 2025

Trends in Avoidable Hospitalizations Before and During the COVID-19 Pandemic: Multiple Cross-Sectional Study Using Administrative Data From Beijing, China.

Trends in Avoidable Hospitalizations Before and During the COVID-19 Pandemic: Multiple Cross-Sectional Study Using Administrative Data From Beijing, China.

Journal: JMIR public health and surveillance

Published: December 07, 2024

Establishment and evaluation of MIRA-qPCR assay for the rapid and sensitively detection of Mycoplasma pneumoniae.

Establishment and evaluation of MIRA-qPCR assay for the rapid and sensitively detection of Mycoplasma pneumoniae.

Journal: Future microbiology

Published: September 11, 2024

Association between nurse-child communication and family caregivers' global ratings to hospital: a retrospective study.

Association between nurse-child communication and family caregivers' global ratings to hospital: a retrospective study.

Journal: Journal of pediatric nursing

Published: May 12, 2024

Safety and immunogenicity of aerosolised Ad5-nCoV, intramuscular Ad5-nCoV, or inactivated COVID-19 vaccine CoronaVac given as the second booster following three doses of CoronaVac: a multicentre, open-label, phase 4, randomised trial.

Safety and immunogenicity of aerosolised Ad5-nCoV, intramuscular Ad5-nCoV, or inactivated COVID-19 vaccine CoronaVac given as the second booster following three doses of CoronaVac: a multicentre, open-label, phase 4, randomised trial.

Journal: The Lancet. Respiratory medicine

Published: December 20, 2022

Antibody persistence and safety after heterologous boosting with orally aerosolised Ad5-nCoV in individuals primed with two-dose CoronaVac previously: 12-month analyses of a randomized controlled trial.

Antibody persistence and safety after heterologous boosting with orally aerosolised Ad5-nCoV in individuals primed with two-dose CoronaVac previously: 12-month analyses of a randomized controlled trial.

Journal: Emerging microbes & infections

Published: December 12, 2022

Safety and immunogenicity of heterologous boost immunisation with an orally administered aerosolised Ad5-nCoV after two-dose priming with an inactivated SARS-CoV-2 vaccine in Chinese adults: a randomised, open-label, single-centre trial.

Safety and immunogenicity of heterologous boost immunisation with an orally administered aerosolised Ad5-nCoV after two-dose priming with an inactivated SARS-CoV-2 vaccine in Chinese adults: a randomised, open-label, single-centre trial.

Journal: The Lancet. Respiratory medicine

Published: January 05, 2022

Heterologous AD5-nCOV plus CoronaVac versus homologous CoronaVac vaccination: a randomized phase 4 trial.

Heterologous AD5-nCOV plus CoronaVac versus homologous CoronaVac vaccination: a randomized phase 4 trial.

Journal: Nature medicine

Published: October 17, 2021

Effectiveness of Disinfectants Suitable for Inactivating SARS-CoV-2 at Cold-Chain Temperature.

Effectiveness of Disinfectants Suitable for Inactivating SARS-CoV-2 at Cold-Chain Temperature.

Journal: Food and environmental virology

Published: October 15, 2021

A proof of concept for neutralizing antibody-guided vaccine design against SARS-CoV-2.

A proof of concept for neutralizing antibody-guided vaccine design against SARS-CoV-2.

Journal: National science review

Published: February 07, 2021

Showing 1-12 of 19

Last Updated: 09/26/2026